Research and Development
10 February 2025
UC Davis researchers achieve total synthesis of ibogaine
UC Davis researchers achieve a breakthrough in synthesising ibogaine, enabling safer drug developmen...
Diseases
Diseases
Diseases
+2
Drugs and Therapies
Research and Development
07 February 2025
The immune cells that fuel food allergies
A new study reveals how specific immune cells contribute to the exaggerated immune response in food ...
Business
+1
Research and Development
06 February 2025
Azenta’s BioArc Ultra powers UK research
UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, ad...
Diseases
View All Related News
Research and Development
10 February 2025
UC Davis researchers achieve total synthesis of ibogaine
UC Davis researchers achieve a breakthrough in synthesising ibogaine, enabling safer drug development for addiction and depression treatment....
Diseases
+2
Drugs and Therapies
Research and Development
07 February 2025
The immune cells that fuel food allergies
A new study reveals how specific immune cells contribute to the exaggerated immune response in food allergies, offering hope for improved treatments in the future....
Business
+1
Research and Development
06 February 2025
Azenta’s BioArc Ultra powers UK research
UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, adding space for 16 million more samples to support vital health research. ...
Research and Development
05 February 2025
Restoring the gut: VE303’s strategy for C. diff relief
A new publication in Nature Medicine highlights the potential of VE303 for preventing recurrent C. difficile infection, detailing its impact on the gut microbiome and immune response....
Diseases
View All Webinars
New Updated Test Webinar – Final Functional Testing
Research and Development
31 July 2025
The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing
Research and Development
24 April 2025